行情

XBI

XBI

美国生科ETF-SPDR
NYSEARCA

实时行情 | 由晨星基金提供

151.60
+3.60
+2.43%
已收盘, 19:16 03/01 EST
开盘
150.17
昨收
148.00
最高
152.28
最低
149.82
成交量
396.93万
成交额
--
52周最高
174.79
52周最低
62.94
总资产
78.46亿
今年以来回报
11.79%
分时
5日
1月
3月
1年
5年
新闻
业绩
蓝鸟生物股价下跌34%,此前该公司暂停了镰状细胞疾病治疗的试验
Shares of Bluebird Bio Inc. slid 34% in premarket trade Tuesday, after the biotech said it is temporarily suspending Phase 1/2 and Phase 3 trials of its LentiGlobin gene therapy for sickle cell disease after a report of a suspected unexpected serious adver...
MarketWatch · 02/16 12:37
FDA延长阿尔茨海默氏病治疗审查期后,Biogen的股价上涨了9%
MarketWatch · 01/29 16:40
Biogen shares jump 9% after FDA extends review period for Alzheimer's treatment
MarketWatch · 01/29 16:40
Moderna on track to deliver 200 million doses of its COVID vaccine to U.S. govt by end-June
Moderna Inc. undefined said Tuesday it is on track to deliver 100 million doses of its COVID-19 vaccine to the U.S. government by end-March and to deliver...
MarketWatch · 01/26 13:19
Boston Scientific to acquire Preventice Solutions for $925 million in cash, up to $300 million in potential milestone payments
MarketWatch · 01/21 12:23
波士顿科学公司将以9.25亿美元现金,最高3亿美元的潜在里程碑付款来收购Preventice Solutions
Boston Scientific Inc. undefined said Thursday it has agreed to acquire privately held Preventice Solutions Inc. for an upfront payment of $925 million and...
MarketWatch · 01/21 12:23
Boston Scientific to acquire Preventice Solutions for $925 million in cash, up to $300 million in potential milestone payments
MarketWatch · 01/21 12:23
UPDATE: Bionano Genomics prices $200 million underwritten stock offering at a discount of $6 a share
Bionano Genomics Inc. undefined priced a $200 million underwritten stock offering announced late Tuesday at a discount of $6 a share, selling 33.3 million...
MarketWatch · 01/20 12:59
更多
暂无数据
了解XBI最新的财务预测,通过XBI每股收益,每股净资产,每股现金流等数据分析美国生科ETF-SPDR近期的经营情况,然后做出明智的投资选择。
暂无数据
评级
评级时间
评级周期
评级机构
评级
2020/08/31
3 年
晨星评级
2020/08/31
5 年
晨星评级
2020/08/31
10 年
晨星评级
  • 业绩
  • 资产分布
  • 分红历史
时间周期
回报率
同类排名
最近一天
-3.9149%
--
近一周
-1.3327%
--
近一月
-6.5522%
--
近三月
2.3267%
--
近六月
18.1541%
--
今年以来
11.7862%
--
近一年
35.5354%
--
近三年
8.0603%
--
近五年
8.1538%
--
近十年
19.4995%
--
成立以来
13.9739%
--
暂无数据
  • 分红
  • 拆股
  • 内部人交易
暂无数据
  • 全部
暂无数据
简况
基金名称
美国生科ETF-SPDR
风险
低风险
成立日期
2006-01-31
业绩比较基准
NASDAQ Composite CR
管理人
State Street Global Advisors Ltd
托管人
State Street Bank & Trust Co
基金经理
Feehily/Schneider/Donofrio